Cargando…
Soluble CD30 is a new biomarker to predict two-year overall survival of adult T cell leukemia/lymphoma patients
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044134/ http://dx.doi.org/10.1186/1742-4690-11-S1-P2 |
| _version_ | 1782319089088200704 |
|---|---|
| author | Pornkuna, Ratiorn Takemoto, Shigeki Hidaka, Michihiro Haga, Yoshio |
| author_facet | Pornkuna, Ratiorn Takemoto, Shigeki Hidaka, Michihiro Haga, Yoshio |
| author_sort | Pornkuna, Ratiorn |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4044134 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40441342014-06-17 Soluble CD30 is a new biomarker to predict two-year overall survival of adult T cell leukemia/lymphoma patients Pornkuna, Ratiorn Takemoto, Shigeki Hidaka, Michihiro Haga, Yoshio Retrovirology Poster Presentation BioMed Central 2014-01-07 /pmc/articles/PMC4044134/ http://dx.doi.org/10.1186/1742-4690-11-S1-P2 Text en Copyright © 2014 Pornkuna et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Pornkuna, Ratiorn Takemoto, Shigeki Hidaka, Michihiro Haga, Yoshio Soluble CD30 is a new biomarker to predict two-year overall survival of adult T cell leukemia/lymphoma patients |
| title | Soluble CD30 is a new biomarker to predict two-year overall survival of adult T cell leukemia/lymphoma patients |
| title_full | Soluble CD30 is a new biomarker to predict two-year overall survival of adult T cell leukemia/lymphoma patients |
| title_fullStr | Soluble CD30 is a new biomarker to predict two-year overall survival of adult T cell leukemia/lymphoma patients |
| title_full_unstemmed | Soluble CD30 is a new biomarker to predict two-year overall survival of adult T cell leukemia/lymphoma patients |
| title_short | Soluble CD30 is a new biomarker to predict two-year overall survival of adult T cell leukemia/lymphoma patients |
| title_sort | soluble cd30 is a new biomarker to predict two-year overall survival of adult t cell leukemia/lymphoma patients |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044134/ http://dx.doi.org/10.1186/1742-4690-11-S1-P2 |
| work_keys_str_mv | AT pornkunaratiorn solublecd30isanewbiomarkertopredicttwoyearoverallsurvivalofadulttcellleukemialymphomapatients AT takemotoshigeki solublecd30isanewbiomarkertopredicttwoyearoverallsurvivalofadulttcellleukemialymphomapatients AT hidakamichihiro solublecd30isanewbiomarkertopredicttwoyearoverallsurvivalofadulttcellleukemialymphomapatients AT hagayoshio solublecd30isanewbiomarkertopredicttwoyearoverallsurvivalofadulttcellleukemialymphomapatients |